Enanta Pharmaceuticals Inc 10-K for FY2020
Enanta Pharmaceuticals Inc (ENTA)
10-K
2020-11-25
For: 2020-09-30
View Original
Added on
April 06, 2026
About this 10-K
Enanta Pharmaceuticals Inc filed this 10-K on November 25, 2020, covering the fiscal year ended September 30, 2020 (FY2020).
Headline figures
Fiscal year ended September 30, 2020, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $122.47M
- down 40.3% from $205.2M a year earlier
- Net loss
- $36.17M
- compared with net income of $46.38M a year earlier
- Diluted EPS
- -$1.81
- compared with $2.21 a year earlier